ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
新橋生物
4.18
+0.1900
4.76%
盤後:
4.23
0.0453
+1.08%
19:59 EST
成交量:
45.04萬
成交額:
184.20萬
市值:
4.82億
市盈率:
-8.53
高:
4.18
開:
4.03
低:
3.90
收:
3.99
52周最高:
6.79
52周最低:
0.5950
股本:
1.15億
流通股本:
4,823.40萬
量比:
0.97
換手率:
0.93%
股息:
- -
股息率:
- -
每股收益(TTM):
-0.4902
每股收益(LYR):
-0.2738
淨資產收益率:
-18.46%
總資產收益率:
-10.36%
市淨率:
2.45
市盈率(LYR):
-15.27
資料載入中...
總覽
公司
新聞資訊
公告
概念
沒有相關數據
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞資訊
新橋生物宣佈將在ESMO-IO大會上公佈Ragistomig擴展性1期臨牀數據
美通社
·
12/04
新橋生物子公司Visara任命兩位眼科領域傑出領袖為首席醫學官和科學顧問委員會主席,加速推進 VIS-101 的全球開發進程
美通社
·
11/21
新橋生物盤中異動 下午盤急速跳水5.08%
市场透视
·
11/21
新橋生物盤中異動 快速上漲5.75%
市场透视
·
11/10
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/NBP"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NBP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NBP\",,,,,undefined,":{"symbol":"NBP","market":"US","secType":"STK","nameCN":"新橋生物","latestPrice":4.18,"timestamp":1764968400000,"preClose":3.99,"halted":0,"volume":450445,"hourTrading":{"tag":"盘后","latestPrice":4.2253,"preClose":4.18,"latestTime":"19:59 EST","volume":13488,"amount":56433.267,"timestamp":1764982793530},"delay":0,"floatShares":48234000,"shares":115266053,"eps":-0.490217,"marketStatus":"休市中","change":0.19,"latestTime":"12-05 16:00:00 EST","open":4.03,"high":4.18,"low":3.9,"amount":1841983.3423624998,"amplitude":0.070175,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.490217,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1765184400000},"marketStatusCode":7,"adr":0,"adrRate":2.3,"listingDate":1579237200000,"exchange":"NASDAQ","adjPreClose":3.99,"preHourTrading":{"tag":"盘前","latestPrice":4.09,"preClose":3.99,"latestTime":"09:27 EST","volume":2489,"amount":9996.983874000001,"timestamp":1764944840444},"postHourTrading":{"tag":"盘后","latestPrice":4.2253,"preClose":4.18,"latestTime":"19:59 EST","volume":13488,"amount":56433.267,"timestamp":1764982793530},"volumeRatio":0.9748541329085144,"impliedVol":1.7461,"impliedVolPercentile":0.3846},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NBP\",,,,,undefined,":{"symbol":"NBP","floatShares":48234000,"roa":"-10.36%","roe":"-18.46%","lyrEps":-0.273814,"volumeRatio":0.9748541329085144,"shares":115266053,"dividePrice":0,"high":4.18,"amplitude":0.070175,"preClose":3.99,"low":3.9,"week52Low":0.595,"pbRate":"2.45","week52High":6.79,"institutionHeld":0,"latestPrice":4.18,"eps":-0.490217,"divideRate":0,"volume":450445,"delay":0,"ttmEps":-0.490217,"open":4.03,"prevYearClose":0.85,"prevWeekClose":3.84,"prevMonthClose":3.84,"prevQuarterClose":3.78,"fiveDayClose":3.84,"twentyDayClose":4.19,"sixtyDayClose":3.9},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NBP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-20","symbol":"NBP","fiscalQuarterEnding":"2025/06","expectedEps":-0.1,"name":null,"time":"盤前","type":"earning","dateTimestamp":1755662400000,"reportTimeType":"pre","actualEps":-0.07},{"market":"US","date":"2025-05-15","symbol":"NBP","fiscalQuarterEnding":"2025/03","expectedEps":-0.07,"name":null,"time":"盤前","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"pre","actualEps":-0.04},{"market":"US","date":"2025-04-03","symbol":"NBP","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1743652800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-11-14","symbol":"NBP","fiscalQuarterEnding":"2024/09","expectedEps":-0.16,"name":null,"time":"盤前","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"pre","actualEps":-0.25},{"market":"US","date":"2024-08-28","symbol":"NBP","fiscalQuarterEnding":"2024/06","expectedEps":-0.51,"name":null,"time":"盤前","type":"earning","dateTimestamp":1724817600000,"reportTimeType":"pre","actualEps":-0.07}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NBP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NBP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":6,"updateTime":1759467600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NBP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NBP","date":"2025-12-05","current":-8.526836,"percent":0.75,"low":-14.267741,"twenty":-12.688201,"median":-12.077138,"eighty":-11.212426,"high":-10.607129,"avg":-12.08175,"sd":0.855232,"marketCap":459911551},"quantilePoints":[{"date":"2025-10-31","current":-13.114792,"twenty":-13.114792,"median":-13.114792,"eighty":-13.114792,"marketCap":524460541},{"date":"2025-11-07","current":-12.077138,"twenty":-13.547148,"median":-12.71126,"eighty":-12.278904,"marketCap":482964762},{"date":"2025-11-14","current":-12.019491,"twenty":-13.114792,"median":-12.278904,"eighty":-12.077138,"marketCap":480659441},{"date":"2025-11-21","current":-12.077138,"twenty":-13.085968,"median":-12.293316,"eighty":-12.077138,"marketCap":482964762},{"date":"2025-11-28","current":-11.068308,"twenty":-13.06291,"median":-12.192433,"eighty":-11.881137,"marketCap":442621643},{"date":"2025-12-05","current":-11.500664,"twenty":-12.688201,"median":-12.077138,"eighty":-11.212426,"marketCap":459911551}],"updateTime":1765095911532},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NBP\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2589836892","title":"新橋生物宣佈將在ESMO-IO大會上公佈Ragistomig擴展性1期臨牀數據","url":"https://stock-news.laohu8.com/highlight/detail?id=2589836892","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589836892?lang=zh_tw&edition=fundamental","pubTime":"2025-12-04 20:58","pubTimestamp":1764853080,"startTime":"0","endTime":"0","summary":"Ragistomig是一款4-1BB × PD-L1双特异性抗体,旨在治疗使用检查点抑制剂后病情复发或效果欠佳的患者。该研究的主要终点是确定ragistomig的剂量限制性毒性和不良事件特征,并观察客观缓解率、药物代谢动力学和免疫原性特征以及其他次要终点。公司的差异化管线主要由givastomig和VIS-101领衔。givastomig正开发用于治疗Claudin 18.2阳性的胃癌及其他胃肠道恶性肿瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4839442_ZH39442_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4139","NBP"],"gpt_icon":0},{"id":"2585171117","title":"新橋生物子公司Visara任命兩位眼科領域傑出領袖為首席醫學官和科學顧問委員會主席,加速推進 VIS-101 的全球開發進程","url":"https://stock-news.laohu8.com/highlight/detail?id=2585171117","media":"美通社","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585171117?lang=zh_tw&edition=fundamental","pubTime":"2025-11-21 14:02","pubTimestamp":1763704920,"startTime":"0","endTime":"0","summary":"两位专家将为VIS-101项目带来宝贵的临床开发专业知识。作为 首席医学官,Rich 博士将全面负责 Visara 的临床职能与研发项目;Quezada-Ruiz 博士则将领导新成立的科学顾问委员会。他们的加入进一步印证了 VIS-101 的巨大潜力,也展现了 Visara 打造世界级组织的决心。\" Visara首席医学官Rich博士表示:\"我致力于通过制定高效的临床及监管策略,加速创新眼科疗法的研发进程,使其尽快惠及患者。我期待与Visara 团队合作,完成II 期研究并推动VIS-101 进入注册开发阶段。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4830740_ZH30740_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["VIS","BK4585","BK4139","NBP","BK4588"],"gpt_icon":0},{"id":"2585549791","title":"新橋生物盤中異動 下午盤急速跳水5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585549791","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585549791?lang=zh_tw&edition=fundamental","pubTime":"2025-11-21 02:37","pubTimestamp":1763663868,"startTime":"0","endTime":"0","summary":"北京时间2025年11月21日02时37分,新桥生物股票出现波动,股价急速下挫5.08%。截至发稿,该股报4.30美元/股,成交量27.6417万股,换手率0.24%,振幅8.83%。机构评级方面,在所有6家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。新桥生物股票所在的生物技术行业中,整体涨幅为0.51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112102374895111263&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112102374895111263&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NBP"],"gpt_icon":0},{"id":"2582368829","title":"新橋生物盤中異動 快速上漲5.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582368829","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582368829?lang=zh_tw&edition=fundamental","pubTime":"2025-11-10 22:38","pubTimestamp":1762785528,"startTime":"0","endTime":"0","summary":"北京时间2025年11月10日22时38分,新桥生物股票出现异动,股价快速拉升5.75%。截至发稿,该股报4.23美元/股,成交量1.2826万股,换手率0.01%,振幅0.71%。新桥生物股票所在的生物技术行业中,整体涨幅为0.62%。其相关个股中,Cogent Biosciences, Inc.、Inflarx N.V.、Pluri Inc.涨幅较大,Inflarx N.V.、Propanc Biopharma, Inc.、Innate Pharma较为活跃,换手率分别为78.22%、15.29%、8.71%,振幅较大的相关个股有Cogent Biosciences, Inc.、Pluri Inc.、Inflarx N.V.,振幅分别为20.18%、20.06%、17.89%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110223848a49788fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110223848a49788fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NBP","BK4139"],"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":9,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/NBP\",params:#limit:6,delay:false,,,undefined,":[]}}